Coagulation is a feature of COVID-19, and it has been shown that consumption of the coagulation factor XIIIA (F13A1) was elevated in COVID-19 patients and tended to be higher in nonsurvivors [57]. This evidence concerns the gene F13A1 and COVID-19.